CD8A and COVID-19: The highly induced virus-specific TH1 and CD8+ T cell immune responses in asymptomatic or mild symptomatic patients may protect them from progressing to severe COVID-19 in the absence of humoral immunity, while potent virus-specific B cell responses likely account for the recovery of patients of moderate or severe COVID-19.